New Brunswick Scientific Co., Inc., Expands World's Most Extensive Shaker Line With Launch of Two New Incubator Models
12 Septembre 2005 - 1:00PM
PR Newswire (US)
EDISON, N.J., Sept. 12 /PRNewswire-FirstCall/ -- New Brunswick
Scientific Co., Inc. (NBS) (NASDAQ:NBSC), today announced that it
has rolled-out two new high-specification incubator shakers, the
benchtop Innova(R) 40 and larger capacity Innova 43, bringing the
total number of shakers in its already comprehensive product
portfolio to more than 30 shaker models-the largest selection
offered by any manufacturer. Both new additions to the Innova(R)
shaker family feature high-temperature capability to 80 degrees C,
optional refrigeration and a programmable controller to automate
changes to any operating parameter. These novel enhancements
increase precision and efficiency for NBS' customers. President and
Chief Operating Officer James Orcutt said: "Accelerated, targeted
new-product development is among several strategic initiatives upon
which NBS is focused, and the results of this sustained effort are
becoming increasingly evident as we move through the year. The
roll-out of the Innova 40 and 43 models represents the first in a
number of new-product launches scheduled for the second half of
2005. "These latest shaker models not only extend and complement
existing products but also offer the competitive advantage of
state-of-the-art, multi- step programming capabilities as well as
improvements to previous product features and optimized
user-friendliness. We continue to invest in our aggressive product
development program and expect a number of new roll-outs in the
months ahead, all of which are intended to enhance shareholder
value." To be added to New Brunswick Scientific's e-mail
distribution list, please click on the link below:
http://www.clearperspectivegroup.com/clearsite/nbsc/emailoptin.html
About New Brunswick Scientific New Brunswick Scientific Co., Inc.,
is a leading global provider of a comprehensive line of research
equipment and scientific instrumentation for use in the life
science industry. The Company's products are used in the creation,
maintenance and control of physical and biochemical environments
required for the growth, detection and storage of microorganisms
for medical, biological and chemical applications, as well as
environmental research and commercial product development. NBS is a
forerunner in the research and development of pioneering equipment
to meet the challenges of new areas of advancement in life science.
Established in 1946, New Brunswick Scientific is headquartered in
Edison, New Jersey, with sales and distribution facilities
strategically located in the United States, Europe and Asia. For
more information, please visit http://www.nbsc.com/ . This press
release contains "forward-looking statements" within the meaning of
the Private Securities Litigation Reform Act of 1995. Forward-
looking statements may be identified by words such as "expects,"
"anticipates," "intends," "plans," "believes," "seeks,"
"estimates," "will" or words of similar meaning and include, but
are not limited to, statements about the expected future business
and financial performance of the Company. The forward-looking
statements involve a number of risks and uncertainties, including
but not limited to, changes in economic conditions, demand for the
Company's products, pricing pressures, intense competition in the
industries in which the Company operates, the need for the Company
to keep pace with technological developments and respond in a
timely manner to changes in customer needs, the Company's
dependence on third-party suppliers, the effect on foreign sales of
currency fluctuations, acceptance of new products, the labor
relations of the Company and its customers and other factors
identified in the Company's Securities and Exchange Commission
filings. Forward-looking statements are based on management's
current expectations and assumptions, which are inherently subject
to uncertainties, risks and changes in circumstances that are
difficult to predict. Actual outcomes and results may differ
materially from these expectations and assumptions due to changes
in global political, economic, business, competitive, market,
regulatory and other factors. The Company undertakes no obligation
to publicly update or review any forward-looking information,
whether as a result of new information, future developments or
otherwise. DATASOURCE: New Brunswick Scientific Co., Inc. CONTACT:
Investors - Samuel Eichenbaum, Vice President, Finance and
Treasurer, New Brunswick Scientific Co., Inc., +1-732-650-2500, ;
Matthew J. Dennis, CFA, of NBS Investor Relations, Clear
Perspective Group, LLC, +1-440.353.0552, Web site:
http://www.nbsc.com/
Copyright
New Brunswick Scientific (NASDAQ:NBSC)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
New Brunswick Scientific (NASDAQ:NBSC)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024